Gut & Microbiome
joint hypermobility increases irritable bowel syndrome
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Population patterns (Observational)
How the studies fall
What the evidence shows
Joint hypermobility raises the odds of irritable bowel syndrome — connective-tissue laxity / dysautonomia driving intestinal dysmotility.
The evidence (11)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Silvernale C, Garcia-Fischer I, Staller K 2024 · Dig Dis Sci | observational | mixed | moderate | IBS/dyspepsia frequency in JHS/EDS driven substantially by psychological-trauma overlap — partly confounded. |
| Chan Y, Chang BW, Kamboj AK, Raphael Y, Sukov R, Rezaie A 2025 · Clinical and translational gastroenterology | observational | tested-null | low | hEDS (n=10) vs healthy (n=20), all with IBS/GI symptoms: no significant difference in visceroptosis or correlation with Beighton score. |
| jh-constipation-2020 2020 · Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences | observational | tested-null | low | Case-control (children): joint hypermobility significantly more frequent in functional constipation vs controls — supports hypermobility->lower-GI dysmotility (constipation phenotype). |
| Alsakarneh S, Al Ta'ani O, Madi MY, Syn WK, Ruffle JK, Aziz Q, Farmer AD 2026 · Alimentary pharmacology & therapeutics | observational | supports | high | TriNetX propensity-matched EDS vs controls (59,128 pairs): IBS 7.3% in EDS, OR 2.6 (95% CI 2.5-2.8, p<0.001). |
| Glayzer JE, McFarlin BL, Castori M, Suarez ML, Meinel MC, Kobak WH, Steffen AD, Schlaeger JM 2021 · Am J Med Genet C Semin Med Genet | observational | contradicts | low | IBS reported in only 6.5% of 1146 women with EDS/HSD — at or below general-population IBS prevalence (~4–12%), i.e. NO evidence of the elevation the claim predicts. |
| Sweerts KWE, Vork L, Mujagic Z, Conchillo JM, Keszthelyi D 2025 · Digestive diseases and sciences | observational | tested-null | low | Prospective GI-motility clinic cohort (n=87; HSD n=23 vs non-HSD n=64): no significant differences in GI symptoms or motility patterns across hypermobility/Beighton subgroups. |
| Choudhary A, Fikree A, Ruffle JK, Takahashi K, Palsson OS, Aziz I, Aziz Q 2025 · Neurogastroenterology and motility | observational | mixed | moderate | hEDS/HSD cohort (n=1044) UMAP-clustered: cluster of n=180 with hEDS/HSD+IBS alone plus a larger IBS+foregut cluster (n=466); no external control group for IBS odds. |
| Zweig A, Schindler V, Becker AS, van Maren A, Pohl D 2018 · Neurogastroenterol Motil | observational | supports | moderate | Higher joint-hypermobility prevalence in constipation-predominant IBS (IBS-C) specifically. |
| Hastings J, Forster JE, Witzeman K 2019 · PM&R | observational | supports | low | G-HSD listed among secondary outcomes as associated with IBS; OR ~4.72 cited by an internal literature survey but NOT present in the official abstract → unverified, full-text-required. |
| Loganathan P, Herlihy D, Gajendran M, Gonzalez Z, Chavez LO, Espino K, McCallum RW 2024 · Journal of investigative medicine : the official publication of the American Federation for Clinical Research | observational | mixed | low | Retrospective case series in a GI motility clinic: JHS prevalence 9.7% of 277 patients; among JHS patients, IBS prevalence 55.5%. |
| Shulman RJ, Self MM, Czyzewski DI, Goldberg J, Heitkemper M 2020 · J Pediatr | observational | contradicts | moderate | Paediatric comparative study (Beighton >=4 and >=6 thresholds), children with IBS/functional abdominal pain vs controls: 'Beighton scores were SIMILAR between groups, as was the proportion with joint hypermobility.' Beighton scores were unrelated to abdominal pain or stooling characteristics; higher scores tracked with somatisation/depression instead. A purpose-built comparison finding no difference - directly disconfirming. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.